Describe Biocon's initial mission.
Answers
Biocon began its mission in 2010 with an aim of addressing some of the roadblocks to faster drug discovery. ... During the first five years, Biocon focused on novel therapeutic target discovery and validation that could be used by industry to develop new therapeutic compounds with a higher probability of success.
Answer:
Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India by Kiran Mazumdar-Shaw, the founder.[4] The Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries[citation needed] across the globe, including the developed markets of the United States and Europe.[4] It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets [provide reference]. In research services, Syngene International Limited (Syngene), a publicly listed subsidiary of Biocon.
Explanation:
plz mark it as brainliest